Neurogene Inc (NGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,647 | -75,144 | -55,630 | -35,413 | -16,921 |
| Depreciation Amortization | -985 | 828 | 989 | 870 | 379 |
| Accounts payable and accrued liabilities | 1,694 | -77 | 339 | 368 | 135 |
| Other Working Capital | -1,414 | -5,961 | -5,065 | -7,628 | -6,749 |
| Other Operating Activity | 2,578 | 9,751 | 6,260 | 4,260 | 1,506 |
| Operating Cash Flow | $-20,774 | $-70,603 | $-53,107 | $-37,543 | $-21,650 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -780 | -808 | -692 | -525 | -65 |
| Purchase Of Investment | -88,965 | -198,453 | -80,203 | -42,654 | N/A |
| Sale Of Investment | 44,700 | 74,000 | 58,250 | 49,500 | 30,000 |
| Investing Cash Flow | $-45,045 | $-125,261 | $-22,645 | $6,321 | $29,935 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -15 | -52 | -39 | -27 | -11 |
| Common Stock Issued | 19 | 191,265 | 1,187 | 1,044 | 629 |
| Other Financing Activity | 0 | -7,142 | -7,142 | -7,142 | -7,142 |
| Financing Cash Flow | $4 | $184,071 | $-5,994 | $-6,125 | $-6,524 |
| Beginning Cash Position | 136,925 | 148,718 | 148,718 | 148,718 | 148,718 |
| End Cash Position | 71,110 | 136,925 | 66,972 | 111,371 | 150,479 |
| Net Cash Flow | $-65,815 | $-11,793 | $-81,746 | $-37,347 | $1,761 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,774 | -70,603 | -53,107 | -37,543 | -21,650 |
| Capital Expenditure | -780 | -808 | -692 | -525 | -65 |
| Free Cash Flow | -21,554 | -71,411 | -53,799 | -38,068 | -21,715 |